scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Sara Jarmakiewicz-Czaja | Q90449156 |
Rafał Filip | Q90449158 | ||
P2093 | author name string | Dominika Piątek | |
P2860 | cites work | The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease | Q90477075 |
Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial Dysbiosis | Q90638800 | ||
Increased genomic damage and vitamin B status in inflammatory bowel disease patients: A case-control, prospective, pilot study | Q90811988 | ||
Effect of the proinflammatory cytokine TNF-α on intestinal riboflavin uptake: inhibition mediated via transcriptional mechanism(s) | Q91198707 | ||
Effects of egg phosvitin on mucosal transcriptional profiles and luminal microbiota composition in murine colon | Q91719134 | ||
Vitamin D Decreases Hepcidin and Inflammatory Markers in Newly Diagnosed Inflammatory Bowel Disease Paediatric Patients: A Prospective Study | Q92167906 | ||
Serum Hepcidin Levels Predict Intestinal Iron Absorption in Patients with Inflammatory Bowel Disease | Q92349474 | ||
Towards a Food Pharmacy: Immunologic Modulation through Diet | Q92493324 | ||
Dietary Composition and Effects in Inflammatory Bowel Disease | Q92989345 | ||
Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature | Q22251115 | ||
Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers | Q24611219 | ||
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa | Q24622141 | ||
Flavonoids in Inflammatory Bowel Disease: A Review | Q26748883 | ||
Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review | Q26823927 | ||
Roles of Zinc Signaling in the Immune System | Q28072508 | ||
Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins | Q28081177 | ||
Iron and zinc nutrition in the economically-developed world: a review | Q28296541 | ||
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response | Q28298985 | ||
Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease | Q33638444 | ||
Emerging Evidence on Neutrophil Motility Supporting Its Usefulness to Define Vitamin C Intake Requirements | Q33749531 | ||
Zinc in Infection and Inflammation | Q33852159 | ||
Vitamin effects on the immune system: vitamins A and D take centre stage | Q34005584 | ||
Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis | Q34170678 | ||
Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease | Q34349248 | ||
Vitamin B6: a long known compound of surprising complexity. | Q34603106 | ||
Lactoferrin, a bird's eye view | Q34637860 | ||
Dietary clues to the pathogenesis of Crohn's disease | Q35195909 | ||
Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways | Q35755435 | ||
Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. | Q36011499 | ||
Production of conjugated linoleic acid and conjugated linolenic acid isomers by Bifidobacterium species | Q43015681 | ||
Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease | Q43836306 | ||
Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease | Q44215391 | ||
Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial | Q44318829 | ||
Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease | Q44974910 | ||
[Nutrigenomics--bioactive dietary components]. | Q45926676 | ||
The role of lactoferrin in the iron metabolism. Part I. Effect of lactofferin on intake, transport and iron storage | Q46252534 | ||
The Imbalance between n-6/n-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Disease: A Comprehensive Review and Future Therapeutic Perspectives | Q47367020 | ||
Immune-enhancing activity of phosvitin by stimulating the production of pro-inflammatory mediator | Q47627733 | ||
Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD). | Q47709746 | ||
Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis | Q47876533 | ||
Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8+ T-cell immunity. | Q48360550 | ||
Flavonoids and the gastrointestinal tract: Local and systemic effects. | Q50114058 | ||
Comprehensive genetic study of fatty acids helps explain the role of noncoding inflammatory bowel disease associated SNPs and fatty acid metabolism in disease pathogenesis. | Q52352001 | ||
The influence of vitamin D on M1 and M2 macrophages in patients with Crohn's disease. | Q52760295 | ||
Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease | Q36252769 | ||
Trans fats-sources, health risks and alternative approach - A review | Q36550637 | ||
Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? | Q36620178 | ||
Ascorbic acid: chemistry, biology and the treatment of cancer. | Q36717267 | ||
Biomarkers of Nutrition for Development (BOND)-Zinc Review | Q36728473 | ||
Forging a field: the golden age of iron biology | Q36742479 | ||
Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease. | Q37118393 | ||
A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis | Q37248661 | ||
Zinc intake and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study | Q37503004 | ||
Ulcerative Colitis and Crohn's Disease Are Associated with Decreased Serum Selenium Concentrations and Increased Cardiovascular Risk | Q37535406 | ||
Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease | Q37558674 | ||
Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases | Q37716897 | ||
Impact of vitamin D on immune function: lessons learned from genome-wide analysis | Q37725587 | ||
Taurine and inflammatory diseases | Q38027405 | ||
Lactoferrin: Antimicrobial activity and therapeutic potential | Q38090855 | ||
Milk-derived proteins and peptides in clinical trials. | Q38135688 | ||
Carotenoids, inflammation, and oxidative stress--implications of cellular signaling pathways and relation to chronic disease prevention | Q38240969 | ||
Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes | Q38323931 | ||
Modulation of inflammation and immunity by dietary conjugated linoleic acid | Q38490318 | ||
Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort - An ECCO-EpiCom study | Q38748245 | ||
The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC. | Q38772843 | ||
VEN-120, a recombinant human lactoferrin, promotes a regulatory T cell (Treg) phenotype and drives resolution of inflammation in distinct murine models of inflammatory bowel disease | Q38804021 | ||
Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases | Q38805575 | ||
Potential benefits of colostrum in gastrointestinal diseases. | Q38878006 | ||
Systematic evaluation on the effectiveness of conjugated linoleic acid in human health | Q38956410 | ||
All-trans retinoic acid attenuates experimental colitis through inhibition of NF-κB signaling | Q38977104 | ||
Reflections About Inflammatory Bowel Disease and Vitamins A and D. | Q38990352 | ||
Diagnosis and treatment of anemia in patients with inflammatory bowel disease | Q39044814 | ||
Domino effect of hypomagnesemia on the innate immunity of Crohn's disease patients | Q39144545 | ||
The resilience of the intestinal microbiota influences health and disease | Q39308455 | ||
Conjugated linoleic acid: A potent fatty acid linked to animal and human health. | Q39459242 | ||
Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls | Q41744891 | ||
Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease | Q41886049 | ||
δ- and γ-tocopherols inhibit phIP/DSS-induced colon carcinogenesis by protection against early cellular and DNA damages | Q42380262 | ||
The intestinal antiinflammatory agent glycomacropeptide has immunomodulatory actions on rat splenocytes | Q42467664 | ||
Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis | Q42873487 | ||
Retinoic acid inhibits tissue factor and HMGB1 via modulation of AMPK activity in TNF-α activated endothelial cells and LPS-injected mice. | Q53196901 | ||
[Do antioxidant vitamins influence carcinogenesis?]. | Q53333321 | ||
Ascorbic acid modulates cell migration in differentiated HL-60 cells and peripheral blood leukocytes. | Q53570454 | ||
Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease. | Q54293140 | ||
Lactoferrin and necrotizing enterocolitis. | Q54295537 | ||
Dietary n-3 PUFA May Attenuate Experimental Colitis. | Q55065244 | ||
Effect of taurine on intestinal recovery following intestinal ischemia-reperfusion injury in a rat | Q57105478 | ||
Role of omega-3 polyunsaturated fatty acids in preventing gastrointestinal cancers: current status and future perspectives | Q57156236 | ||
New Insights into the Role of Trace Elements in IBD | Q58761184 | ||
Carotenoids as natural antioxidants | Q59191881 | ||
Cross-Sectional Analysis of Overall Dietary Intake and Mediterranean Dietary Pattern in Patients with Crohn's Disease | Q59807374 | ||
The Role of Dietary Nutrients in Inflammatory Bowel Disease | Q61448106 | ||
Dietary interventions for induction and maintenance of remission in inflammatory bowel disease | Q61920298 | ||
Implications of the Westernized Diet in the Onset and Progression of IBD. | Q64928327 | ||
Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer | Q73701179 | ||
The influence of deficiencies of essential trace elements and vitamins on the course of Crohn's disease | Q85618520 | ||
A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides | Q86257596 | ||
[Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases] | Q86997503 | ||
Lifestyle alters GUT-bacteria function: Linking immune response and host | Q88135346 | ||
Vitamin Producing Lactic Acid Bacteria as Complementary Treatments for Intestinal Inflammation | Q88587142 | ||
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel | Q88774533 | ||
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) | Q89680367 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | inflammatory bowel diseases | Q917447 |
P304 | page(s) | 2894169 | |
P577 | publication date | 2020-02-27 | |
P1433 | published in | Journal of Nutrition and Metabolism | Q26841852 |
P1476 | title | The Influence of Nutrients on Inflammatory Bowel Diseases | |
P478 | volume | 2020 |
Search more.